Susquehanna International Group LLP purchased a new position in Ultralife Co. (NASDAQ:ULBI) in the fourth quarter, Holdings Channel reports. The fund purchased 12,134 shares of the technology company’s stock, valued at approximately $79,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Marshall Wace North America L.P. bought a new stake in Ultralife during the first quarter worth approximately $36,000. JPMorgan Chase & Co. grew its position in Ultralife by 22.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 10,207 shares of the technology company’s stock worth $63,000 after purchasing an additional 1,864 shares in the last quarter. Rhumbline Advisers purchased a new position in Ultralife during the 4th quarter worth approximately $72,000. Brandywine Global Investment Management LLC grew its position in Ultralife by 17.8% during the 4th quarter. Brandywine Global Investment Management LLC now owns 12,585 shares of the technology company’s stock worth $81,000 after purchasing an additional 1,900 shares in the last quarter. Finally, Bailard Inc. bought a new stake in Ultralife in the fourth quarter worth $159,000. 35.01% of the stock is currently owned by institutional investors.

Separately, Benchmark assumed coverage on shares of Ultralife in a research report on Thursday, April 1st. They set a “buy” rating and a $12.00 target price for the company.

Ultralife stock opened at $7.85 on Wednesday. The firm has a fifty day moving average price of $7.92 and a two-hundred day moving average price of $6.85. The firm has a market cap of $125.56 million, a price-to-earnings ratio of 26.17 and a beta of 1.57. The company has a debt-to-equity ratio of 0.02, a current ratio of 3.58 and a quick ratio of 1.87. Ultralife Co. has a fifty-two week low of $5.10 and a fifty-two week high of $9.20.

Ultralife (NASDAQ:ULBI) last announced its quarterly earnings data on Thursday, February 4th. The technology company reported $0.17 EPS for the quarter. The business had revenue of $28.98 million during the quarter. Ultralife had a net margin of 4.33% and a return on equity of 5.36%.

Ultralife Company Profile

Ultralife Corp. engages in the manufacture and sale of products for power solutions. It operates through the Battery & Energy Products and Communications System segments. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, thin cell and various other non-rechargeable batteries, in addition to rechargeable batteries, uninterruptable power supplies, charging systems, and accessories such as cables.

Featured Article: Golden Cross

Want to see what other hedge funds are holding ULBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ultralife Co. (NASDAQ:ULBI).

Institutional Ownership by Quarter for Ultralife (NASDAQ:ULBI)

Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.